通光線纜(300265.SZ):2021年度淨利預降12.27%-32.51%
格隆匯1月28日丨通光線纜(300265.SZ)披露2021年度業績預吿,預計2021年度實現歸屬於上市公司股東的淨利潤4000萬元-5200萬元,同比下降12.27%-32.51%;歸屬於上市公司股東的扣除非經常性損益後的淨利潤2800萬元-3600萬元,同比下降20.47%-38.14%。
報吿期,公司營業收入較上年同期上升約30%,但受上游原材料特別是鋁材等價格持續上漲的影響,公司綜合毛利率下降。雖然公司針對鋁材開展了套期保值業務,但未能完全抵消現貨市場中價格波動的風險。
報吿期非經常性損益影響歸屬於上市公司股東的淨利潤金額約為1400萬元,主要為政府補助等。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.